STAT3 and posterior cortical atrophy: However, due to the promiscuous nature of STAT3 signaling in so many cell types, the future success of potential therapies may possibly entail cell-specific delivery of STAT3 targeting or co-targeting with other known drivers of PCa progression to obtain optimal results.